Effects of eplerenone on glucose metabolism and blood pressure in hypertensive patients with obesity
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2019
Price : $35 *
At a glance
- Drugs Eplerenone (Primary) ; Trichlormethiazide
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 24 Apr 2019 Status changed from active, no longer recruiting to completed.
- 20 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 17 Apr 2015 According to UMIN, the date for data entry closure is 2016/12/31, and the date for conclusion of data analysis is 2017/02/28.